|
1
|
Graceffa G, Salamone G, Contino S, Saputo F, Corigliano A, Melfa G, Proclamà MP, Richiusa P, Mazzola S, Tutino R, et al: Risk factors for anaplastic thyroid carcinoma: A case series from a tertiary referral center for thyroid surgery and literature analysis. Front Oncol. 12(948033)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rao SN and Smallridge RC: Anaplastic thyroid cancer: An update. Best Pract Res Clin Endocrinol Metab. 37(101678)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Talbott I and Wakely PE Jr: Undifferentiated (anaplastic) thyroid carcinoma: Practical immunohistochemistry and cytologic look-alikes. Semin Diagn Pathol. 32:305–310. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jannin A, Escande A, Al Ghuzlan A, Blanchard P, Hartl D, Chevalier B, Deschamps F, Lamartina L, Lacroix L, Dupuy C, et al: Anaplastic thyroid carcinoma: An Update. Cancers (Basel). 14(1061)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
de Ridder M, Nieveen van Dijkum E, Engelsman A, Kapiteijn E, Klumpen HJ and Rasch CRN: Anaplastic thyroid carcinoma: A nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades. Eur J Endocrinol. 183:203–209. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Milella M, Falcone I, Conciatori F, Cesta Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S, Cognetti F and Ciuffreda L: PTEN: Multiple functions in human malignant tumors. Front Oncol. 5(24)2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT and McGowan EM: PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy. Mol Cancer. 17(37)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cain RJ and Ridley AJ: Phosphoinositide 3-kinases in cell migration. Biol Cell. 101:13–29. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ward PS and Thompson CB: Signaling in control of cell growth and metabolism. Cold Spring Harb Perspect Biol. 4(a006783)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yehia L, Keel E and Eng C: The clinical spectrum of PTEN Mutations. Annu Rev Med. 71:103–116. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH and Baker SJ: Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res. 64:7773–7779. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nagy R, Ganapathi S, Comeras I, Peterson C, Orloff M, Porter K, Eng C, Ringel MD and Kloos RT: Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid. 21:505–510. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rustad CF, Bjornslett M, Heimdal KR, Maehle L, Apold J and Moller P: Germline PTEN mutations are rare and highly penetrant. Hered Cancer Clin Pract. 4:177–185. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bandargal S, Rajab M, Forest VI, Pusztaszeri MP, Hier MP, da Silva SD and Payne RJ: Characteristics of PTEN mutation in thyroid tumours: A retrospective chart review. Cancers (Basel). 15(1575)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou J, Song Y, Zhan W, Wei X, Zhang S, Zhang R, Gu Y, Chen X, Shi L, Luo X, et al: Thyroid imaging reporting and data system (TIRADS) for ultrasound features of nodules: Multicentric retrospective study in China. Endocrine. 72:157–170. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang Y, Zheng H, Xu M, Maeda N, Tsunedomi R, Kishi H, Nagano H and Kobayashi S: Fyn-Mediated paxillin tyrosine 31 phosphorylation regulates migration and invasion of breast cancer cells. Int J Mol Sci. 24(15980)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dum D, Menz A, Volkel C, De Wispelaere N, Hinsch A, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, et al: Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol. 126(104762)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Berr AL, Wiese K, Dos Santos G, Koch CM, Anekalla KR, Kidd M, Davis JM, Cheng Y, Hu YS and Ridge KM: Vimentin is required for tumor progression and metastasis in a mouse model of non-small cell lung cancer. Oncogene. 42:2074–2087. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Davey MG, Hynes SO, Kerin MJ, Miller N and Lowery AJ: Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers (Basel). 13(4455)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hu X, He S, Jiang X, Wei P, Zhou X, Shi Z, Li X, Lu J, Zhao H, Wei B and Jin M: Reticular fibre structure in the differential diagnosis of parathyroid neoplasms. Diagn Pathol. 18(79)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Källberg M, Cox AJ, Kruglyak S and Saunders CT: Manta: Rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 32:1220–1222. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nagaiah G, Hossain A, Mooney CJ, Parmentier J and Remick SC: Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol. 2011(542358)2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Luongo F, Colonna F, Calapa F, Vitale S, Fiori ME and De Maria R: PTEN Tumor-Suppressor: The dam of stemness in cancer. Cancers (Basel). 11(1076)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Leslie NR and Longy M: Inherited PTEN mutations and the prediction of phenotype. Semin Cell Dev Biol. 52:30–38. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Song MS, Salmena L and Pandolfi PP: The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 13:283–296. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bonneau D and Longy M: Mutations of the human PTEN gene. Hum Mutat. 16:109–122. 2000.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dillon LM and Miller TW: Therapeutic targeting of cancers with loss of PTEN function. Curr Drug Targets. 15:65–79. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al: Highly accurate protein structure prediction with AlphaFold. Nature. 596:583–589. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, Yuan D, Stroe O, Wood G, Laydon A, et al: AlphaFold protein structure database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50(D1):D439–D444. 2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Danielsen SA, Lind GE, Bjornslett M, Meling GI, Rognum TO, Heim S and Lothe RA: Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation-status. Hum Mutat. 29:E252–E262. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kim RH, Wang X, Evans AJ, Campbell SC, Nguyen JK, Farncombe KM and Eng C: Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome. NPJ Genom Med. 5(40)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pistorius S, Klink B, Pablik J, Rump A, Aust D, Garzarolli M, Schröck E and Schackert HK: An unusual case of Cowden syndrome associated with ganglioneuromatous polyposis. Hered Cancer Clin Pract. 14(11)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, Rocco EG, Criscitiello C, Malapelle U and Invernizzi M: PTEN alterations and their role in cancer management: Are we making headway on precision medicine? Genes (Basel). 11(719)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Owen S, Alken S, Alshami J, Guiot MC, Kavan P, Reardon DA, Muanza T, Gibson N, Pemberton K, Solca F, et al: Genomic analysis of tumors from patients with glioblastoma with long-term response to afatinib. Onco Targets Ther. 15:367–380. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lee Y and Oh YL: Thyroid pathology, a clue to PTEN hamartoma tumor syndrome. J Pathol Transl Med. 57:178–183. 2023.PubMed/NCBI View Article : Google Scholar
|
